Mortality in patients undergoing revascularization with paclitaxel eluting devices for infrainguinal peripheral artery disease: Insights from a network meta‐analysis of randomized trials-Reference-Cited by-同舟云学术

Mortality in patients undergoing revascularization with paclitaxel eluting devices for infrainguinal peripheral artery disease: Insights from a network meta‐analysis of randomized trials

Published:2020-07-21 Issue:4 Volume:96 Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Kuno Toshiki¹^ORCID,Ueyama Hiroki¹,Mikami Takahisa¹,Takagi Hisato²,Numasawa Yohei³,Anzai Hitoshi⁴,Bangalore Sripal⁵

Affiliation:

1. Department of Medicine, Icahn School of Medicine at Mount Sinai Mount Sinai Beth Israel New York USA

2. Department of Cardiovascular Surgery Shizuoka Medical Center Shizuoka Japan

3. Department of Cardiology Japanese Red Cross Ashikaga Hospital Ashikaga Japan

4. Department of Cardiology SUBARU Health Insurance Ota Memorial Hospital Ota Japan

5. Division of Cardiovascular Medicine New York University School of Medicine New York USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29125

Reference85 articles.

1. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions

2. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery

3. Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive

4. Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

5. Mortality Assessment of Paclitaxel-Coated Balloons

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of drug-coated balloon angioplasty in patients with dyslipidemia in the BIOLUX P-III registry: A subgroup analysis;Vascular;2024-08-19

2. Comparing Endovascular Approaches in Lower Extremity Artery Disease: Insights from a Network Meta-Analysis;Journal of Clinical Medicine;2024-02-10

3. Activated Carbon-Enriched Electrospun-Produced Scaffolds for Drug Delivery/Release in Biological Systems;International Journal of Molecular Sciences;2023-04-04

4. Influence of Elongation of Paclitaxel-Eluting Electrospun-Produced Stent Coating on Paclitaxel Release and Transport through the Arterial Wall after Stenting;Polymers;2021-04-05

5. Randomized controlled trials and real-world evidence for market access and surveillance of high-risk products—The example of paclitaxel;Gefässchirurgie;2020-11-27